UY27855A1 - CHEMICAL COMPOUNDS - Google Patents

CHEMICAL COMPOUNDS

Info

Publication number
UY27855A1
UY27855A1 UY27855A UY27855A UY27855A1 UY 27855 A1 UY27855 A1 UY 27855A1 UY 27855 A UY27855 A UY 27855A UY 27855 A UY27855 A UY 27855A UY 27855 A1 UY27855 A1 UY 27855A1
Authority
UY
Uruguay
Prior art keywords
compounds
carboxypeptidase
solvates
pharmaceutically acceptable
chemical compounds
Prior art date
Application number
UY27855A
Other languages
Spanish (es)
Inventor
Magnus Polla
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to UY27855A priority Critical patent/UY27855A1/en
Publication of UY27855A1 publication Critical patent/UY27855A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compuestos de fórmula (I) , solvatos y sales farmacéuticamente aceptables de los mismos, o solvatos de dichas sales, inhibidores de carboxipeptidasa U, por tanto útiles para prevención y tratamiento de enfermedades donde la inhibición de la carboxipeptidasa U es beneficiosa. La invención se refiere también a: - compuestos de la invención para utilizar en terapia; - procesos de preparación de dichos compuestos nuevos; - composiciones farmacéuticas conteniendo por lo menos un compuesto de la invención, o un solvato o sal farmacéuticamente aceptable de los mismos, como ingrediente activo; - el uso de compuestos activos en fabricación de medicamentos para uso médico referido.Compounds of formula (I), solvates and pharmaceutically acceptable salts thereof, or solvates of said salts, inhibitors of carboxypeptidase U, therefore useful for prevention and treatment of diseases where inhibition of carboxypeptidase U is beneficial. The invention also relates to: - compounds of the invention for use in therapy; - processes for preparing said new compounds; - pharmaceutical compositions containing at least one compound of the invention, or a pharmaceutically acceptable solvate or salt thereof, as active ingredient; - the use of active compounds in the manufacture of medicinal products for referred medical use.

UY27855A 2003-06-16 2003-06-16 CHEMICAL COMPOUNDS UY27855A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27855A UY27855A1 (en) 2003-06-16 2003-06-16 CHEMICAL COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27855A UY27855A1 (en) 2003-06-16 2003-06-16 CHEMICAL COMPOUNDS

Publications (1)

Publication Number Publication Date
UY27855A1 true UY27855A1 (en) 2003-12-31

Family

ID=38812786

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27855A UY27855A1 (en) 2003-06-16 2003-06-16 CHEMICAL COMPOUNDS

Country Status (1)

Country Link
UY (1) UY27855A1 (en)

Similar Documents

Publication Publication Date Title
UY29085A1 (en) PIRIMIDINE DERIVATIVES 4-SULFONAMID SUBSTITUTED, INTERMEDIATE COMPOUNDS FOR PREPARATION, PREPARATION PROCEDURES, MEDICINAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
PA8591701A1 (en) PIRROLOPIRIMIDINE DERIVATIVES
BR0317294A (en) Compound, pharmaceutical formulation, use of a compound, methods for prevention and / or treatment of conditions associated with glycogen synthase kinase-3 and disease prevention and / or treatment, and use of intermediates
SE9901573D0 (en) New compounds
UA90858C2 (en) Controlled-release formulations containing vardenafil
SE0200979D0 (en) New compounds
CO5580767A2 (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE
AR029403A1 (en) N-SUBSTITUTED DERIVATIVES OF CARBAMOILOXIALQUIL-AZOLIO, A PROCESS FOR ITS MANUFACTURE, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT
GB0112348D0 (en) Compounds
BRPI0409427A (en) compound, use thereof, pharmaceutical composition, method of treating a human suffering from a hyperproliferative disease, and process for the preparation of a compound or a pharmaceutically acceptable salt, ester or prodrug thereof
TW200606164A (en) New compounds
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
BR0307588A (en) Compound, gsk-3 inhibitor, pharmaceutical composition, and therapeutic or preventative agent for a disease
TW200800984A (en) New compounds
MX2021014372A (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same.
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
UA83832C2 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200634002A (en) Chemical compounds
TW200716618A (en) Chemical compounds
SE9901572D0 (en) New compounds
SE0201837D0 (en) Chemical compounds
ITMI20042475A1 (en) USE OF THIAZOLIDINONIC DERIVATIVES AS THERAPEUTIC AGENTS
UY26459A1 (en) 3,4-DIHIDROQUINAZOLINES 5,6-DISSTITUTED
UY27855A1 (en) CHEMICAL COMPOUNDS
SE9900190D0 (en) New compounds

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150415